+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Subarachnoid Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Subarachnoid Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Thrombotic Microangiopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Thrombotic Microangiopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Transient Ischemic Attack - Pipeline Insight, 2024 - Product Thumbnail Image

Transient Ischemic Attack - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Varicose Veins - Pipeline Insight, 2024 - Product Thumbnail Image

Varicose Veins - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Vascular Malformations - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Malformations - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ventricular Dysfunction - Pipeline Insight, 2024 - Product Thumbnail Image

Ventricular Dysfunction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Intracerebral hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Intracerebral hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Mitral Valve Insufficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Mitral Valve Insufficiency - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Vascular Ehlers-Danlos Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Ehlers-Danlos Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Left Ventricular Dysfunction - Pipeline Insight, 2024 - Product Thumbnail Image

Left Ventricular Dysfunction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic Thromboembolic Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Thromboembolic Pulmonary Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dilated Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Intermittent Claudication - Pipeline Insight, 2024 - Product Thumbnail Image

Intermittent Claudication - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ischemia Reperfusion Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Ischemic Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemic Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pulmonary embolism - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary embolism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Raynaud's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Raynaud's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Portal Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Portal Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more